The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Apoptosis Assays-Global Market Insights and Sales Trends 2025

Apoptosis Assays-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1857271

No of Pages : 113

Synopsis
Apoptosis (programmed cell death) is the genetically controlled ablation of cells during normal development. Apoptosis is distinct from necrosis in both the biochemical and the morphological changes that occur. In contrast to necrotic cells, apoptotic cells are characterized morphologically by compaction of the nuclear chromatin, shrinkage of the cytoplasm and production of membrane-bound apoptotic bodies.
The global Apoptosis Assays market size is expected to reach US$ 4852.5 million by 2029, growing at a CAGR of 6.0% from 2023 to 2029. The market is mainly driven by the significant applications of Apoptosis Assays in various end use industries. The expanding demands from the Drug Discovery & Development, Clinical & Diagnostic Applications, Basic Research and Stem Cell Research, are propelling Apoptosis Assays market. Caspase Assays, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Annexin V and Cell Permeability Assays segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Apoptosis Assays market, driven by demand from China, the second largest economy with some signs of stabilising, the Apoptosis Assays market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Apoptosis Assays, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Apoptosis Assays market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Apoptosis Assays market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Apoptosis Assays sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Apoptosis Assays covered in this report include Merck, Thermo Fisher Scientific, Becton Dickinson, Bio-Rad Laboratories, Promega Corporation, Abcam, Bio-Techne, Sartorius and Biotium, etc.
The global Apoptosis Assays market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Thermo Fisher Scientific
Becton Dickinson
Bio-Rad Laboratories
Promega Corporation
Abcam
Bio-Techne
Sartorius
Biotium
Creative Bioarray
Geno Technology
GeneCopoeia
Danaher
GE Healthcare
PerkinElmer
Global Apoptosis Assays market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Apoptosis Assays market, Segment by Type:
Caspase Assays
Annexin V and Cell Permeability Assays
DNA Fragmentation Assays
Mitochondrial Assays
Global Apoptosis Assays market, by Application
Drug Discovery & Development
Clinical & Diagnostic Applications
Basic Research
Stem Cell Research
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Apoptosis Assays companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Apoptosis Assays
1.1 Apoptosis Assays Market Overview
1.1.1 Apoptosis Assays Product Scope
1.1.2 Apoptosis Assays Market Status and Outlook
1.2 Global Apoptosis Assays Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Apoptosis Assays Market Size by Region (2018-2029)
1.4 Global Apoptosis Assays Historic Market Size by Region (2018-2023)
1.5 Global Apoptosis Assays Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Apoptosis Assays Market Size (2018-2029)
1.6.1 North America Apoptosis Assays Market Size (2018-2029)
1.6.2 Europe Apoptosis Assays Market Size (2018-2029)
1.6.3 Asia-Pacific Apoptosis Assays Market Size (2018-2029)
1.6.4 Latin America Apoptosis Assays Market Size (2018-2029)
1.6.5 Middle East & Africa Apoptosis Assays Market Size (2018-2029)
2 Apoptosis Assays Market by Type
2.1 Introduction
2.1.1 Caspase Assays
2.1.2 Annexin V and Cell Permeability Assays
2.1.3 DNA Fragmentation Assays
2.1.4 Mitochondrial Assays
2.2 Global Apoptosis Assays Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Apoptosis Assays Historic Market Size by Type (2018-2023)
2.2.2 Global Apoptosis Assays Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Apoptosis Assays Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Apoptosis Assays Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Apoptosis Assays Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Apoptosis Assays Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Apoptosis Assays Revenue Breakdown by Type (2018-2029)
3 Apoptosis Assays Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery & Development
3.1.2 Clinical & Diagnostic Applications
3.1.3 Basic Research
3.1.4 Stem Cell Research
3.2 Global Apoptosis Assays Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Apoptosis Assays Historic Market Size by Application (2018-2023)
3.2.2 Global Apoptosis Assays Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Apoptosis Assays Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Apoptosis Assays Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Apoptosis Assays Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Apoptosis Assays Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Apoptosis Assays Revenue Breakdown by Application (2018-2029)
4 Apoptosis Assays Competition Analysis by Players
4.1 Global Apoptosis Assays Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Apoptosis Assays as of 2022)
4.3 Date of Key Players Enter into Apoptosis Assays Market
4.4 Global Top Players Apoptosis Assays Headquarters and Area Served
4.5 Key Players Apoptosis Assays Product Solution and Service
4.6 Competitive Status
4.6.1 Apoptosis Assays Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Apoptosis Assays Products, Services and Solutions
5.1.4 Merck Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Apoptosis Assays Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Becton Dickinson
5.3.1 Becton Dickinson Profile
5.3.2 Becton Dickinson Main Business
5.3.3 Becton Dickinson Apoptosis Assays Products, Services and Solutions
5.3.4 Becton Dickinson Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.3.5 Bio-Rad Laboratories Recent Developments
5.4 Bio-Rad Laboratories
5.4.1 Bio-Rad Laboratories Profile
5.4.2 Bio-Rad Laboratories Main Business
5.4.3 Bio-Rad Laboratories Apoptosis Assays Products, Services and Solutions
5.4.4 Bio-Rad Laboratories Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.4.5 Bio-Rad Laboratories Recent Developments
5.5 Promega Corporation
5.5.1 Promega Corporation Profile
5.5.2 Promega Corporation Main Business
5.5.3 Promega Corporation Apoptosis Assays Products, Services and Solutions
5.5.4 Promega Corporation Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.5.5 Promega Corporation Recent Developments
5.6 Abcam
5.6.1 Abcam Profile
5.6.2 Abcam Main Business
5.6.3 Abcam Apoptosis Assays Products, Services and Solutions
5.6.4 Abcam Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.6.5 Abcam Recent Developments
5.7 Bio-Techne
5.7.1 Bio-Techne Profile
5.7.2 Bio-Techne Main Business
5.7.3 Bio-Techne Apoptosis Assays Products, Services and Solutions
5.7.4 Bio-Techne Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Techne Recent Developments
5.8 Sartorius
5.8.1 Sartorius Profile
5.8.2 Sartorius Main Business
5.8.3 Sartorius Apoptosis Assays Products, Services and Solutions
5.8.4 Sartorius Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.8.5 Sartorius Recent Developments
5.9 Biotium
5.9.1 Biotium Profile
5.9.2 Biotium Main Business
5.9.3 Biotium Apoptosis Assays Products, Services and Solutions
5.9.4 Biotium Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.9.5 Biotium Recent Developments
5.10 Creative Bioarray
5.10.1 Creative Bioarray Profile
5.10.2 Creative Bioarray Main Business
5.10.3 Creative Bioarray Apoptosis Assays Products, Services and Solutions
5.10.4 Creative Bioarray Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.10.5 Creative Bioarray Recent Developments
5.11 Geno Technology
5.11.1 Geno Technology Profile
5.11.2 Geno Technology Main Business
5.11.3 Geno Technology Apoptosis Assays Products, Services and Solutions
5.11.4 Geno Technology Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.11.5 Geno Technology Recent Developments
5.12 GeneCopoeia
5.12.1 GeneCopoeia Profile
5.12.2 GeneCopoeia Main Business
5.12.3 GeneCopoeia Apoptosis Assays Products, Services and Solutions
5.12.4 GeneCopoeia Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.12.5 GeneCopoeia Recent Developments
5.13 Danaher
5.13.1 Danaher Profile
5.13.2 Danaher Main Business
5.13.3 Danaher Apoptosis Assays Products, Services and Solutions
5.13.4 Danaher Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.13.5 Danaher Recent Developments
5.14 GE Healthcare
5.14.1 GE Healthcare Profile
5.14.2 GE Healthcare Main Business
5.14.3 GE Healthcare Apoptosis Assays Products, Services and Solutions
5.14.4 GE Healthcare Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.14.5 GE Healthcare Recent Developments
5.15 PerkinElmer
5.15.1 PerkinElmer Profile
5.15.2 PerkinElmer Main Business
5.15.3 PerkinElmer Apoptosis Assays Products, Services and Solutions
5.15.4 PerkinElmer Apoptosis Assays Revenue (US$ Million) & (2018-2023)
5.15.5 PerkinElmer Recent Developments
6 North America
6.1 North America Apoptosis Assays Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Apoptosis Assays Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Apoptosis Assays Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Apoptosis Assays Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Apoptosis Assays Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Apoptosis Assays Market Dynamics
11.1 Apoptosis Assays Industry Trends
11.2 Apoptosis Assays Market Drivers
11.3 Apoptosis Assays Market Challenges
11.4 Apoptosis Assays Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’